To reinforce the antitumor efficacy of B16F10/GPI-IL-21 in the B16F10 melanoma-bearing C57BL/6 mice, we down regulated the TGF-β1 expression in the B16F10 cells by the RNAi technology and injection of miR200c agomir simultaneously. Here, IL21 is linked to melanoma.